Renal cancer stem cell-derived sEVs impair renal function by inducing renal cell ERS and apoptosis in mice

Ruoyu Wu1, Zhiguo Chen1, Junjie Ma1

  • 1Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Abstract

Insights

Small extracellular vesicles from renal cancer stem cells (RCSCs) impair kidney function by inducing apoptosis and endoplasmic reticulum stress. These RCSC-derived sEVs carry miR-142-3p, which targets ERp44, leading to renal cell damage and functional decline.

Area of Science:

  • Oncology
  • Nephrology
  • Cell Biology

Background:

  • Cancer stem cells (CSCs) drive tumor progression and metastasis.
  • CSCs release extracellular vesicles (EVs) that influence the tumor microenvironment.
  • The impact of small EVs (sEVs) from renal CSCs (RCSCs) on kidney function remains uninvestigated.

Purpose of the Study:

  • To investigate the effect of RCSC-derived sEVs on renal function.
  • To elucidate the mechanisms by which RCSC-sEVs impact kidney cells.

Main Methods:

  • RCSC-sEVs were isolated and injected into mouse kidneys.
  • Renal function was assessed via urinary protein and serum creatinine levels.
  • Pathological changes, apoptosis, and endoplasmic reticulum stress (ERS) were analyzed using PAS, IHC, WB, FCM, RT-qPCR, and TUNEL assays.

Main Results:

  • RCSC-sEVs induced apoptosis and ERS in mouse kidneys, leading to decreased renal function.
  • In vivo studies showed increased urinary protein and serum creatinine after RCSC-sEV injection.
  • In vitro, RCSC-sEVs induced HK2 cell ERS and apoptosis via miR-142-3p, targeting ERp44 and activating the PERK-CHOP pathway.

Conclusions:

  • RCSC-sEVs contribute to renal function impairment during tumor development.
  • RCSC-sEVs act as vectors for miR-142-3p, inducing ERS and apoptosis in normal renal cells.
  • This process results in functional decline of the kidney.

Related Concept Videos